期刊
CANCER LETTERS
卷 307, 期 2, 页码 200-210出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2011.04.004
关键词
IGFBP-3; NF-kappa B; Apoptosis; Chemodrug; Caspase
类别
资金
- US Department of Defense [PC040971, PC061151]
Nuclear factor-kappaB (NF-kappa B) is constitutively activated in a variety of human cancers including prostate cancer and involved in tumorigenesis, tumor progression and chemoresistance. Insulin-like growth factor-binding protein-3 (IGFBP-3) is a potent tumor suppressor and is significantly suppressed in a variety of cancers. Diverse biological effects of IGFBP-3 have been reported to be both dependent and independent of the IGF/IGF-I receptor (IGF-IR) axis. The precise underlying mechanisms of IGF/IGF-IR-independent, antiproliferative actions of IGFBP-3 are yet to be elucidated. We found an inverse correlation between NF-kappa B activity and IGFBP-3 expression during prostate cancer progression using an in vitro prostate cancer progression model. Restoration of IGFBP-3 resulted in significant inhibition of constitutively elevated NF-kappa B activity in prostate cancer cells. IGFBP-3 further inhibited the expression of NF-kappa B-regulated angiogenic factors such as VEGF and IL-8, and cell adhesion molecules, ICAM-1 and VCAM-1. This inhibitory action of IGFBP-3 was IGF/IGF-IR-independent since IGFBP-3 mutant devoid of IGF binding affinity had a similar inhibitory effect. We identified that IGFBP-3 degrades the key NF-kappa B regulatory molecules-I kappa B alpha and p65-NF-kappa B proteins through activation of caspase-8 and -3/-7, thereby inhibiting elevated NF-kappa B activity in prostate cancer. Finally intratumoral administration of IGFBP-3 resulted in significant tumor suppression as well as sensitization of antitumor effect of doxorubicin. Our findings indicate that IGFBP-3 exerts antitumor effects via IGF-independent mechanisms which involve activation of caspase-dependent apoptosis and cross-talk with NF-kappa B signaling. The use of IGFBP-3 as a cancer therapeutic with this distinctive suppression mechanism may offer alternate means to treat chemotherapy resistant tumors. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据